Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital

Single-dose intraoperative radiotherapy during lumpectomy for breast cancer: an innovative patient-centred treatment

Research output: Contribution to journalComment/debateResearchpeer-review

  1. CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Breast cancer survival in Nordic BRCA2 mutation carriers-unconventional association with oestrogen receptor status

    Research output: Contribution to journalJournal articleResearchpeer-review

  • on behalf of the TARGIT-A trial authors
View graph of relations

In the randomised TARGIT-A trial, risk-adapted targeted intraoperative radiotherapy (TARGIT-IORT) during lumpectomy was non-inferior to whole-breast external beam radiotherapy, for local recurrence. In the long-term, no difference was found in any breast cancer outcome, whereas there were fewer deaths from non-breast-cancer causes. TARGIT-IORT should be included in pre-operative consultations with eligible patients.

Original languageEnglish
JournalBritish Journal of Cancer
Issue number9
Pages (from-to)1469–1474
Number of pages6
Publication statusPublished - Apr 2021

ID: 66209158